Thangaraj Devadoss

756 total citations
38 papers, 616 citations indexed

About

Thangaraj Devadoss is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Thangaraj Devadoss has authored 38 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 16 papers in Organic Chemistry. Recurrent topics in Thangaraj Devadoss's work include Neurotransmitter Receptor Influence on Behavior (17 papers), Synthesis and Biological Evaluation (15 papers) and Stress Responses and Cortisol (9 papers). Thangaraj Devadoss is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (17 papers), Synthesis and Biological Evaluation (15 papers) and Stress Responses and Cortisol (9 papers). Thangaraj Devadoss collaborates with scholars based in India, Malaysia and Australia. Thangaraj Devadoss's co-authors include Radhakrishnan Mahesh, Shvetank Bhatt, Yeshwant Kurhe, Deepali Gupta, Mahesh Radhakrishnan, Ankur Jindal, Santhepete Nanjundaiah Manjula, Dilip K. Pandey, Niraj Kumar Jha and Dinesh Kumar Chellappan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Psychopharmacology and European Journal of Pharmacology.

In The Last Decade

Thangaraj Devadoss

38 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thangaraj Devadoss India	16	186	170	149	145	134	38	616
Elżbieta Żmudzka Poland	12	155 0.8×	116 0.7×	165 1.1×	38 0.3×	76 0.6×	18	463
Michael P. Clay United States	8	156 0.8×	152 0.9×	315 2.1×	66 0.5×	97 0.7×	11	553
Davide Amato Germany	17	236 1.3×	91 0.5×	399 2.7×	208 1.4×	49 0.4×	31	1.1k
Abdalla Elhwuegi Libya	8	137 0.7×	139 0.8×	180 1.2×	24 0.2×	125 0.9×	19	545
István Gacsályi Hungary	14	235 1.3×	66 0.4×	327 2.2×	106 0.7×	87 0.6×	27	630
Mahesh Radhakrishnan India	15	136 0.7×	174 1.0×	226 1.5×	21 0.1×	146 1.1×	25	626
Irena Romańska Poland	18	268 1.4×	88 0.5×	558 3.7×	90 0.6×	85 0.6×	52	927
Natalia Malikowska‐Racia Poland	14	98 0.5×	45 0.3×	119 0.8×	77 0.5×	58 0.4×	29	371
Ali Razmi Iran	12	82 0.4×	102 0.6×	92 0.6×	43 0.3×	142 1.1×	24	467
Anna Dziubina Poland	16	188 1.0×	74 0.4×	297 2.0×	50 0.3×	37 0.3×	31	567

Countries citing papers authored by Thangaraj Devadoss

Since Specialization

Citations

This map shows the geographic impact of Thangaraj Devadoss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thangaraj Devadoss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thangaraj Devadoss more than expected).

Fields of papers citing papers by Thangaraj Devadoss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thangaraj Devadoss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thangaraj Devadoss. The network helps show where Thangaraj Devadoss may publish in the future.

Co-authorship network of co-authors of Thangaraj Devadoss

This figure shows the co-authorship network connecting the top 25 collaborators of Thangaraj Devadoss. A scholar is included among the top collaborators of Thangaraj Devadoss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thangaraj Devadoss. Thangaraj Devadoss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bhatt, Shvetank, Thangaraj Devadoss, Niraj Kumar Jha, et al.. (2022). Targeting inflammation: a potential approach for the treatment of depression. Metabolic Brain Disease. 38(1). 45–59. 51 indexed citations

Bhatt, Shvetank, et al.. (2020). 5-HT3 Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders. Current Neuropharmacology. 19(9). 1545–1559. 68 indexed citations

Bhatt, Shvetank, Radhakrishnan Mahesh, Ankur Jindal, & Thangaraj Devadoss. (2016). Neuropharmacological and neurochemical evaluation of N - n - propyl-3-ethoxyquinoxaline-2-carboxamide (6n): a novel serotonergic 5-HT ₃ receptor antagonist for co-morbid antidepressant- and anxiolytic-like potential using traumatic brain injury model in rats. Journal of Basic and Clinical Physiology and Pharmacology. 28(2). 93–100. 8 indexed citations

Bhatt, Shvetank, Radhakrishnan Mahesh, Thangaraj Devadoss, & Ankur Jindal. (2016). Neuropharmacological evaluation of a novel 5-HT ₃ receptor antagonist (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl) methanone (6g) on lipopolysaccharide-induced anxiety models in mice. Journal of Basic and Clinical Physiology and Pharmacology. 28(2). 101–106. 15 indexed citations

Gupta, Deepali, Mahesh Radhakrishnan, Thangaraj Devadoss, & Yeshwant Kurhe. (2015). Pharmacological evaluation of novel 5-HT ₃ receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery. Journal of Pharmacy And Bioallied Sciences. 7(2). 103–103. 8 indexed citations

Gupta, Deepali, Thangaraj Devadoss, & Mahesh Radhakrishnan. (2015). A novel 5HT3 antagonist 4i (N-(3-chloro-2-methylphenyl)quinoxalin-2-carboxamide) prevents diabetes-induced depressive phenotypes in mice: Modulation of serotonergic system. Behavioural Brain Research. 297. 41–50. 18 indexed citations

Kurhe, Yeshwant, Radhakrishnan Mahesh, Deepali Gupta, & Thangaraj Devadoss. (2014). Effect of (4a) a novel 5-HT ₃ receptor antagonist on chronic unpredictable mild stress induced depressive-like behavior in mice: an approach using behavioral tests battery. Journal of Basic and Clinical Physiology and Pharmacology. 26(1). 25–33. 9 indexed citations

Bhatt, Shvetank, Radhakrishnan Mahesh, Ankur Jindal, & Thangaraj Devadoss. (2014). Neuropharmacological effect of novel 5-HT3 receptor antagonist, N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n) on chronic unpredictable mild stress-induced molecular and cellular response: Behavioural and biochemical evidences. Pharmacological Reports. 66(5). 804–810. 11 indexed citations

Kurhe, Yeshwant, Radhakrishnan Mahesh, Deepali Gupta, & Thangaraj Devadoss. (2014). QCM-4, a serotonergic type 3 receptor modulator attenuates depression co-morbid with obesity in mice: An approach based on behavioral and biochemical investigations. European Journal of Pharmacology. 740. 611–618. 17 indexed citations

10.

Gupta, Deepali, Mahesh Radhakrishnan, Thangaraj Devadoss, & Yeshwant Kurhe. (2014). Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. European Journal of Pharmacology. 735. 59–67. 23 indexed citations

11.

Bhatt, Shvetank, Radhakrishnan Mahesh, Ankur Jindal, & Thangaraj Devadoss. (2014). Protective effects of a novel 5-HT3 receptor antagonist, N-n-butyl-3-methoxy quinoxaline-2-carboxamide (6o) against chronic unpredictable mild stress-induced behavioral changes and biochemical alterations. Pharmacology Biochemistry and Behavior. 122. 234–239. 8 indexed citations

12.

Kurhe, Yeshwant, Radhakrishnan Mahesh, Thangaraj Devadoss, & Deepali Gupta. (2014). Antidepressant-like effect of a novel 5-HT₃ receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests. Journal of Pharmacology and Pharmacotherapeutics. 5(3). 197–202. 7 indexed citations

13.

Gupta, Deepali, et al.. (2014). Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression. Acta Pharmacologica Sinica. 35(12). 1493–1503. 25 indexed citations

14.

Kurhe, Yeshwant, Radhakrishnan Mahesh, & Thangaraj Devadoss. (2014). QCM-4, a 5-HT3 receptor antagonist ameliorates plasma HPA axis hyperactivity, leptin resistance and brain oxidative stress in depression and anxiety-like behavior in obese mice. Biochemical and Biophysical Research Communications. 456(1). 74–79. 23 indexed citations

15.

Bhatt, Shvetank, et al.. (2013). Anxiolytic-like effect of (4-benzylpiperazin-1-yl)(3-methoxyquinoxalin-2-yl)methanone (6g) in experimental mouse models of anxiety. Indian Journal of Pharmacology. 45(3). 248–248. 7 indexed citations

16.

Mahesh, Radhakrishnan, et al.. (2013). Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests. Indian Journal of Pharmacology. 45(4). 348–348. 10 indexed citations

17.

Mahesh, Radhakrishnan, et al.. (2012). Ligand‐Based Design, Synthesis, and Pharmacological Evaluation of 3‐Methoxyquinoxalin‐2‐carboxamides as Structurally Novel Serotonin Type‐3 Receptor Antagonists. Archiv der Pharmazie. 345(9). 687–694. 8 indexed citations

18.

Mahesh, Radhakrishnan, et al.. (2012). Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n). Journal of Young Pharmacists. 4(4). 235–244. 15 indexed citations

19.

Mahesh, Radhakrishnan, et al.. (2010). Design, synthesis and structure–activity relationship of novel quinoxalin-2-carboxamides as 5-HT3 receptor antagonists for the management of depression. Bioorganic & Medicinal Chemistry Letters. 20(22). 6773–6776. 19 indexed citations

20.

Mahesh, Radhakrishnan, et al.. (2010). Discovery of new anti-depressants from structurally novel 5-HT3 receptor antagonists: Design, synthesis and pharmacological evaluation of 3-ethoxyquinoxalin-2-carboxamides. Bioorganic & Medicinal Chemistry Letters. 21(4). 1253–1256. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact